EUVIMEDEUVIMED entdecken
Crossref

Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease

Vikram R Shaw iD, Jinyoung Byun, Younghun Han, Jeffrey M Cohen iD, Christopher I Amos

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Vikram R Shaw und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Psoriasis, Crohn Disease, Life Style. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Medical Scientist Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis and Crohn disease (CD) are epidemiologically associated with each other. The contribution of genetics and modifiable lifestyle factors to the development of comorbid disease is unclear.

Objectives

To investigate the associations between polygenic risk score (PRS) and modifiable lifestyle factors and the development of comorbid psoriasis and CD.

Methods

This is a prospective cohort study utilizing PRS and survey data on modifiable lifestyle factors. We examined their associations with the development of comorbid psoriasis and CD in patients of European ancestry in the UK Biobank. Kaplan–Meier survival analysis and multivariable Cox proportional hazards regression models were used to evaluate the association between the studied variables and the risk of comorbid disease development.

Results

The study included 430 758 participants, with 124 cases (comorbid psoriasis and CD) and 430 634 controls. A significant difference (P < 0.001; log-rank test) in disease-free survival time was observed across the four genetic risk groups (higher vs. lower risk). In the multivariable Cox proportional hazards regression analysis, the PsO-Hi and CD-Hi groups demonstrated a higher hazard ratio than the PsO-Lo and CD-Lo genetic reference group (hazard ratio 8.34, 95% confidence interval 4.17–16.7; P < 0.001). This trend was also observed in both the group with psoriasis onset first and the group with CD onset first.

Conclusions

These findings suggest that the development of comorbid psoriasis and CD is significantly associated with a higher genetic risk of both conditions, a trend that was consistent regardless of the disease of first onset. Future studies should validate these findings in an independent cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisCrohn DiseaseLife StyleHumansMaleFemaleProspective StudiesMiddle AgedAdultRisk FactorsComorbidityGenetic Predisposition to DiseaseProportional Hazards ModelsUnited KingdomKaplan-Meier EstimateCase-Control StudiesMultifactorial Inheritance

Autor:innen und Institutionen

  • Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.
  • Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM, USA.
  • Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.

ORCID-Profile: Vikram R Shaw, Jeffrey M Cohen

Förderung

  • Medical Scientist Training Program

Zitieren

APA

Shaw, V. R., Byun, J., Han, Y., Cohen, J. M., & Amos, C. I. (2025). Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf285

Vancouver

Shaw VR, Byun J, Han Y, Cohen JM, Amos CI. Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf285

BibTeX
@article{Shaw2025,
  author = {Shaw, Vikram R and Byun, Jinyoung and Han, Younghun and Cohen, Jeffrey M and Amos, Christopher I},
  title = {Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf285}
}
Kostenlos starten →